ALTERNA THERAPEUTICS

Alterna Therapeutics is a biotechnology company developing precision RNA-based therapies for diseases associated with abnormal RNA splicing. Originating from research at the Centre for Genomic Regulation, the company uses splice-switching antisense oligonucleotides to redirect RNA processing, aiming to restore functional protein production or suppress harmful proteins without modifying DNA. Its proprietary platform combines high-throughput splicing analysis, regulatory network data, and rational oligonucleotide design to identify therapeutic opportunities for genetic and other complex diseases with significant unmet medical needs.